Your Health, We Care
Release date: 2024-07-09 10:17:20 Article From: Lucius Laos Recommended: 355
At the beginning of May, Lucius Pharmaceutical (Laos) Co., Ltd. officially obtained the approval of the Ministry of Health of the People's Republic of China and launched 8 products! And obtained the approval certificate.
Cabozantinib approval number certificate
Crizotinib document number certificate
Eltrombopag 25mg document number certificate
Avatribopa letter number certificate
It is believed that in the future, under the leadership of the chairman of Lucius Pharmaceutical, and also under the strict supervision of the State Food and Drug Administration, the development of Lucius Pharmaceutical will get better and better.
Deputy commissioner of the FDA and president of Lucious Pharmaceuticals
Officials from the Lao State Food and Drug Administration paid close attention to the development of local pharmaceutical companies, and organized inspection teams to visit Lucius Pharmaceutical's GMP factory many times, especially for the quality control of local pharmaceutical companies. After all, an explanation to the people of the country is also to improve the high-quality development of the country's pharmaceutical industry to standardize and provide a good development environment!
The director of the Food and Drug Administration personally visited Lucius Park to guide the work, and gave great support to the development of the local high-end pharmaceutical manufacturing industry, and the requirements were also very standardized and strict! And I hope that Lucius Pharmaceutical will introduce advanced pharmaceutical people to Laos and contribute to the development of Laos!
At a grand pharmaceutical exhibition held recently in Dubai, Lucius Company of Laos was in the spotlight for its outstanding performance. Their booth attracted a large audience and···【more】
Recommended：400Release date: 2024-07-09
On October 18-19, 2023, Dr. Luís Meirinhos Soares, a microbiology expert appointed by the World Health Organization (WHO) and director of the Microbiology Laboratory of the Nationa···【more】
Recommended：397Release date: 2024-07-09
On October 19, 2023, the World Health Organization (WHO) conducted a comprehensive inspection of the Lucius Pharmaceutical factory in Laos. The results of this assessment are encou···【more】
Recommended：459Release date: 2024-07-09
At present, the competition in all walks of life is very fierce, especially in the pharmaceutical industry, Lucius Pharmaceutical was established in Vientiane, Laos in 2020, with a···【more】
Recommended：325Release date: 2024-07-09
Here are some key points about Lucius Pharmaceutical:Lucius Pharmaceuticals has state-of-the-art facilities, including factories designed and constructed in strict accordance with ···【more】
Recommended：533Release date: 2024-07-09
From the Black Sea, the most terrifying ocean on earth, to the Mediterranean Sea, Lucius Pharmaceuticals stands on the only Turkish Strait that connects the two seas, announcing Lu···【more】
Recommended：326Release date: 2024-07-09
As we all know, from the perspective of the universe, our solar system is very small, but from the perspective of the earth, it is very huge, the edge of the solar system is the Oo···【more】
Recommended：344Release date: 2024-07-09
At the beginning of May, Lucius Pharmaceutical (Laos) Co., Ltd. officially obtained the approval of the Ministry of Health of the People's Republic of China and launched 8 prod···【more】
Recommended：356Release date: 2024-07-09
The BRAF inhibitor known as Braftovi, manufactured by the French company pierre Fabre.What is the price of Braftovi per box? Where can it be purchased?Currently, there are two main···【more】
Recommended：439Release date: 2024-07-08
Dr. Louis, a microbiologist at the World Health Organization (WHO), recently made a technical visit to Lucius Pharmaceuticals in Laos. The purpose of the visit was to learn more ab···【more】
Recommended：507Release date: 2024-07-09
Lung cancer is the most rapidly increasing malignant tumor with the fastest increasing morbidity and mortality, which has been troubling medical workers. Clinical studies have foun···【more】
Recommended：399Release date: 2024-07-09
On November 21, 2025, the U.S. Food and Drug Administration (FDA) approved the regimen of pembrolizumab (Keytruda, Merck & Co., Inc.) or pembrolizumab and berahyaluronidase alf···【more】
Recommended：159Release date: 2025-12-17
On December 12, 2025, the U.S. Food and Drug Administration (FDA) approved niraparib in combination with abiraterone acetate (brand name: Akeega, Janssen Biotech, Inc.) plus predni···【more】
Recommended：153Release date: 2025-12-15
The U.S. Food and Drug Administration (FDA) announced today that it has approved Omisirge (omidubicel-onlv), the first hematopoietic stem cell transplantation (HSCT) therapy for th···【more】
Recommended：171Release date: 2025-12-10
On December 4, 2025, the U.S. Food and Drug Administration (FDA) approved lisocabtagene maraleucel (Breyanzi, developed by Juno Therapeutics, a subsidiary of Bristol Myers Squibb) ···【more】
Recommended：153Release date: 2025-12-08
On December 3, 2025, the U.S. Food and Drug Administration (FDA) granted full approval to pirtobrutinib (Jaypirca, Eli Lilly and Company) for the treatment of adult patients with r···【more】
Recommended：187Release date: 2025-12-04
Primary analysis data from the randomized, double-blind, placebo-controlled phase III HER2CLIMB-02 study showed that for patients with HER2-positive locally advanced or metastatic ···【more】
Recommended：168Release date: 2025-12-01
The Cure SMA Foundation, a global leading non-profit organization dedicated to spinal muscular atrophy (SMA), announced today its welcome for the U.S. Food and Drug Administration ···【more】
Recommended：163Release date: 2025-11-27
On November 14, 2024, the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) issued favorable opinions, proposing an amendment to the mark···【more】
Recommended：425Release date: 2025-01-13
Recent advancements have reaffirmed the significance of liquid biopsy in the management of advanced solid tumors, although further prospective research is still required. Historica···【more】
Recommended：373Release date: 2025-01-06
FDA Approves First Generic Version of Victoza (liraglutide injection)The U.S. Food and Drug Administration (FDA) has given the green light to the first generic version of Victoza (···【more】
Recommended：452Release date: 2024-12-30
The new indication involves the treatment of adult patients with locally advanced, unresectable non-small cell lung cancer with tumors with EGFR exon 19 deletion or exon 21 (L858R)···【more】
Recommended：361Release date: 2024-12-24
he U.S. Food and Drug Administration (FDA) has approved Crenessity (crinecerfont) for use in combination with glucocorticoids (steroids) to help manage androgen (testosterone-like ···【more】
Recommended：379Release date: 2024-12-17
Lucius Pharmaceuticals (Lao) LTD. (Lucius Pharmaceuticals), with its manufacturing campus in Laos located in the capital city of Vientiane in 2020, officially begins its great journey to make effective and affordable medicines available to people in need around the world...More
Lucius Pharmaceutical Co., Ltd., was established in 2020 in Vientiane, the capital of Laos. It aims to offer safe, effective, and affordable medicines globally. With a factory spanning 25,000 square meters, the company manufactures 200+ generic drugs in diverse therapeutic fields.
Address:No.26 Thongmang village, Xaythany district, Vientiane Capital, Laos
E-mail:laoslucius@gmail.com
Whatsapp:
